ZNF202 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62814206561279E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.57207580286922E-13 |
Normal-vs-Stage2 |
1.188810E-04 |
Normal-vs-Stage3 |
6.4024000545615E-09 |
Normal-vs-Stage4 |
7.77430000376E-08 |
Stage1-vs-Stage2 |
7.934600E-01 |
Stage1-vs-Stage3 |
5.347800E-01 |
Stage1-vs-Stage4 |
6.057000E-01 |
Stage2-vs-Stage3 |
5.499800E-01 |
Stage2-vs-Stage4 |
8.989200E-01 |
Stage3-vs-Stage4 |
3.464600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.69897429458388E-12 |
Normal-vs-AfricanAmerican |
1.01609999969554E-07 |
Normal-vs-Asian |
8.515000E-03 |
Caucasian-vs-AfricanAmerican |
2.563800E-01 |
Caucasian-vs-Asian |
8.991700E-02 |
AfricanAmerican-vs-Asian |
2.234400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.96480675752309E-12 |
Normal-vs-Female |
5.77315972805081E-15 |
Male-vs-Female |
9.882300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.101000E-03 |
Normal-vs-Age(41-60Yrs) |
1.03361763592602E-13 |
Normal-vs-Age(61-80Yrs) |
8.04734057169298E-12 |
Normal-vs-Age(81-100Yrs) |
4.383300E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.940400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.829000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.401800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.546600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.747600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.243600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.193170E-04 |
Normal-vs-Grade 2 |
5.58442181386454E-14 |
Normal-vs-Grade 3 |
2.01120231579921E-11 |
Normal-vs-Grade 4 |
3.7459000000073E-05 |
Grade 1-vs-Grade 2 |
1.410990E-01 |
Grade 1-vs-Grade 3 |
3.818500E-02 |
Grade 1-vs-Grade 4 |
1.107990E-02 |
Grade 2-vs-Grade 3 |
2.496800E-01 |
Grade 2-vs-Grade 4 |
7.820000E-02 |
Grade 3-vs-Grade 4 |
3.059600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.55431223447522E-15 |
Normal-vs-ccB subtype |
1.77140000445775E-08 |
ccA subtype-vs-ccB subtype |
7.699100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.42950104478723E-12 |
Normal-vs-N1 |
2.956400E-02 |
N0-vs-N1 |
1.925590E-01 |
|
|